Italy asked to fully implement EU medicines law to support generic drug competition
This article was originally published in SRA
The European Commission has given Italy two months to fully implement the provisions of the EU medicines legislation on marketing authorisation procedures for generic drugs1. Implementation of the provisions would override an Italian law that currently puts generics manufacturers at a disadvantage on the market.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.